Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations
BACKGROUND: Pertussis is an acute infectious illness, caused by the bacteria Bordetella
pertussis and commonly known as “whooping cough”. Waning immunity after vaccination or …
pertussis and commonly known as “whooping cough”. Waning immunity after vaccination or …
The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin
MS Conover, GP Sloan, CF Love… - Molecular …, 2010 - Wiley Online Library
Many respiratory pathogens establish persistent infection or a carrier state in the human
nasopharynx without overt disease symptoms but the presence of these in the lungs usually …
nasopharynx without overt disease symptoms but the presence of these in the lungs usually …
Immunizing school-age children and adolescents: experience from low-and middle-income countries
MS Mackroth, K Irwin, J Vandelaer, J Hombach… - Vaccine, 2010 - Elsevier
OBJECTIVE: Given the increased attention on the need for booster immunizations of older
children and adolescents, as well as new primary vaccine series that specifically target …
children and adolescents, as well as new primary vaccine series that specifically target …
Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
TA Westra, R de Vries, JJ Tamminga, CJ Sauboin… - Clinical …, 2010 - Elsevier
Background: Pertussis is a highly contagious respiratory disease. Despite a high rate of
vaccine coverage through the Dutch national immunization program, the incidence of …
vaccine coverage through the Dutch national immunization program, the incidence of …
[PDF][PDF] Tdap vaccination during pregnancy to reduce pertussis infection in young infants
JN Matlow, A Pupco, P Bozzo, G Koren - Canadian Family Physician, 2013 - cfp.ca
Tdap vaccination during pregnancy to reduce pertussis infection in young infants Page 1 Vol
59: MAY • MAI 2013 | Canadian Family Physician • Le Médecin de famille canadien 497 …
59: MAY • MAI 2013 | Canadian Family Physician • Le Médecin de famille canadien 497 …
Cross-Species Protection Mediated by a Bordetella bronchiseptica Strain Lacking Antigenic Homologs Present in Acellular Pertussis Vaccines
N Sukumar, GP Sloan, MS Conover, CF Love… - Infection and …, 2010 - Am Soc Microbiol
ABSTRACT The Bordetella species are Gram-negative bacterial pathogens that are
characterized by long-term colonization of the mammalian respiratory tract and are …
characterized by long-term colonization of the mammalian respiratory tract and are …
Immunisation of adolescents in the UK
AR Kale, MD Snape - Archives of disease in childhood, 2011 - adc.bmj.com
The recent introduction of routine immunisation against human papillomavirus (HPV) in
adolescent girls in the UK has focused attention on the potential for immunisation in this age …
adolescent girls in the UK has focused attention on the potential for immunisation in this age …
[PDF][PDF] EFECTIVIDAD DE LA VACUNA ACELULAR ANTIPERTUSSIS EN ADOLESCENTES: UNA REVISIÓN SISTEMÁTICA.
CJN Ruiz - repository.urosario.edu.co
EFECTIVIDAD DE LA VACUNA ACELULAR ANTIPERTUSSIS EN ADOLESCENTES: UNA
REVISIÓN SISTEMÁTICA. Autor Carmen Judith Niño Ruiz, MD Page 1 1 EFECTIVIDAD DE LA …
REVISIÓN SISTEMÁTICA. Autor Carmen Judith Niño Ruiz, MD Page 1 1 EFECTIVIDAD DE LA …
[PDF][PDF] Epidemiological characteristics of the whooping cough in Serbia and Sumadia region
M Djordjevic, V Pantovic, B Jovanovic… - Acta Medica …, 2009 - publisher.medfak.ni.ac.rs
Whooping cough-pertussis (MKB-10: A37) is an acute, infective disease caused by the
sensitive gram negative pleomorphic bacterium Bordatella pertussis. There are other …
sensitive gram negative pleomorphic bacterium Bordatella pertussis. There are other …
[HTML][HTML] Efectividad a corto plazo de la vacuna antipertusis en adolescentes: revisión sistemática
C Niño-Ruiz, L Morón-Duarte, MI Álvarez-Larrañaga - Infectio, 2015 - Elsevier
Introducción La incidencia de la tosferina ha mostrado un incremento en los últimos años,
afectando predominantemente a los niños menores de un año, adolescentes y adultos. En …
afectando predominantemente a los niños menores de un año, adolescentes y adultos. En …